Topics

LifeArc receives $1.2b in Keytruda royalties

08:11 EDT 24 May 2019 | PharmaTimes

In 2016, LifeArc sold a small proportion of its Keytruda royalty interest for $150 million to a private equity fund.

Original Article: LifeArc receives $1.2b in Keytruda royalties

NEXT ARTICLE

More From BioPortfolio on "LifeArc receives $1.2b in Keytruda royalties"

Quick Search